Healthcare provider profile · identity verified

Adil M Waheed, MD

Allopathic & Osteopathic Physicians|Hospitalist · CHAMBERSBURG, PA · NPI 1578757803

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Adil M Waheed, MD received $66.48 in general payments during 2025 across 3 reported records.

Novo Nordisk Inc accounted for 35.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Nuedexta by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$66.48

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$23.79	35.8%	1	2025
Stryker Corporation	Unresolved — no canonical attribution shown	$21.59	32.5%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$21.10	31.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$66.48	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$23.79	1	2025
Source payment records 2025-11-14 · Novo Nordisk Inc · $23.79 · Open Payments source
CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit	Device	Stryker Corporation	$21.59	1	2025
Source payment records 2025-05-02 · Stryker Corporation · $21.59 · Open Payments source
FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s	Device	Stryker Corporation	$21.59	1	2025
Source payment records 2025-05-02 · Stryker Corporation · $21.59 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$21.10	1	2025
Source payment records 2025-06-05 · Otsuka America Pharmaceutical, Inc. · $21.10 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	NUEDEXTA open payments reported associated product	CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901	Nuedexta · 2024 Exact normalized brand match · 1 Part D row	51	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	2200	158
Amlodipine Besylate	Amlodipine Besylate	1507	80
Furosemide	Furosemide	1329	96
Eliquis	Apixaban	1238	102
Gabapentin	Gabapentin	1119	94
Lisinopril	Lisinopril	1095	65
Levothyroxine Sodium	Levothyroxine Sodium	1072	78
Metoprolol Succinate	Metoprolol Succinate	1012	69
Tamsulosin Hcl	Tamsulosin Hcl	957	64
Metoprolol Tartrate	Metoprolol Tartrate	929	74
Pantoprazole Sodium	Pantoprazole Sodium	802	74
Sertraline Hcl	Sertraline Hcl	744	58
Clopidogrel	Clopidogrel Bisulfate	720	47
Metformin Hcl	Metformin Hcl	700	47
Potassium Chloride	Potassium Chloride	699	61
Levetiracetam	Levetiracetam	629	34
Quetiapine Fumarate	Quetiapine Fumarate	617	36
Divalproex Sodium	Divalproex Sodium	581	32
Escitalopram Oxalate	Escitalopram Oxalate	525	41
Pravastatin Sodium	Pravastatin Sodium	525	26
Simvastatin	Simvastatin	455	22
Carvedilol	Carvedilol	452	35
Duloxetine Hcl	Duloxetine Hcl	445	37
Losartan Potassium	Losartan Potassium	439	24
Mirtazapine	Mirtazapine	431	39
Warfarin Sodium	Warfarin Sodium	423	22
Rosuvastatin Calcium	Rosuvastatin Calcium	402	21
Omeprazole	Omeprazole	369	35
Allopurinol	Allopurinol	363	20
Donepezil Hcl	Donepezil Hcl	358	25
Hydralazine Hcl	Hydralazine Hcl	353	30
Trazodone Hcl	Trazodone Hcl	348	27
Buspirone Hcl	Buspirone Hcl	342	20
Finasteride	Finasteride	335	21
Memantine Hcl	Memantine Hcl	331	21
Trulicity	Dulaglutide	305	17
Amiodarone Hcl	Amiodarone Hcl	302	23
Jardiance	Empagliflozin	288	21
Fluoxetine Hcl	Fluoxetine Hcl	284	13
Risperidone	Risperidone	284	22
Baclofen	Baclofen	279	20
Montelukast Sodium	Montelukast Sodium	275	19
Citalopram Hbr	Citalopram Hydrobromide	273	18
Xarelto	Rivaroxaban	270	15
Famotidine	Famotidine	262	30
Olanzapine	Olanzapine	244	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	243	24
Benztropine Mesylate	Benztropine Mesylate	202	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	193	11
Lamotrigine	Lamotrigine	169	suppressed
Spironolactone	Spironolactone	166	14
Carbidopa-Levodopa	Carbidopa/Levodopa	164	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	151	suppressed
Torsemide	Torsemide	145	14
Clonidine Hcl	Clonidine Hcl	143	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	138	15
Venlafaxine Hcl Er	Venlafaxine Hcl	136	suppressed
Haloperidol	Haloperidol	128	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	127	26
Anastrozole	Anastrozole	121	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	121	suppressed
Propranolol Hcl	Propranolol Hcl	119	suppressed
Bumetanide	Bumetanide	116	19
Topiramate	Topiramate	115	suppressed
Calcitriol	Calcitriol	109	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	107	11
Carbidopa-Levodopa Er	Carbidopa/Levodopa	106	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	106	suppressed
Bupropion Hcl Sr	Bupropion Hcl	97	suppressed
Ropinirole Hcl	Ropinirole Hcl	96	suppressed
Midodrine Hcl	Midodrine Hcl	94	16
Lurasidone Hcl	Lurasidone Hcl	92	suppressed
Alendronate Sodium	Alendronate Sodium	87	12
Glimepiride	Glimepiride	82	suppressed
Lansoprazole	Lansoprazole	81	11
Metformin Hcl Er	Metformin Hcl	81	suppressed
Prednisone	Prednisone	81	18
Aripiprazole	Aripiprazole	80	suppressed
Amantadine	Amantadine Hcl	79	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	79	28
Primidone	Primidone	75	suppressed
Sucralfate	Sucralfate	72	suppressed
Oxcarbazepine	Oxcarbazepine	71	suppressed
Glipizide Er	Glipizide	69	suppressed
Januvia	Sitagliptin Phosphate	69	suppressed
Calcium Acetate	Calcium Acetate	68	suppressed
Bupropion Xl	Bupropion Hcl	65	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	64	31
Amitriptyline Hcl	Amitriptyline Hcl	62	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	62	suppressed
Scopolamine	Scopolamine	62	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	59	suppressed
Lorazepam	Lorazepam	59	32
Nitroglycerin	Nitroglycerin	59	55
Metoclopramide Hcl	Metoclopramide Hcl	58	suppressed
Phenytoin	Phenytoin	58	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	55	48
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	55	21
Carbamazepine	Carbamazepine	54	suppressed
Atenolol	Atenolol	53	suppressed
Benazepril Hcl	Benazepril Hcl	53	suppressed
Oxycodone Hcl	Oxycodone Hcl	53	30
Carbamazepine Er	Carbamazepine	52	suppressed
Ethosuximide	Ethosuximide	52	suppressed
Rytary	Carbidopa/Levodopa	52	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	51	suppressed
Latanoprost	Latanoprost	51	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	51	suppressed
Solifenacin Succinate	Solifenacin Succinate	51	suppressed
Tradjenta	Linagliptin	51	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	49	12
Zenpep	Lipase/Protease/Amylase	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	12
Glipizide	Glipizide	46	suppressed
Lovastatin	Lovastatin	46	suppressed
Entresto	Sacubitril/Valsartan	45	suppressed
Megestrol Acetate	Megestrol Acetate	45	suppressed
Sotalol	Sotalol Hcl	45	suppressed
Insulin Aspart Flexpen	Insulin Aspart	44	17
Dapsone	Dapsone	43	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	24
Propranolol Hcl Er	Propranolol Hcl	42	suppressed
Tramadol Hcl	Tramadol Hcl	42	18
Budesonide	Budesonide	41	suppressed
Glucagon Emergency Kit	Glucagon	41	37
Ondansetron Hcl	Ondansetron Hcl	41	27
Pioglitazone Hcl	Pioglitazone Hcl	41	suppressed
Cephalexin	Cephalexin	40	20
Creon	Lipase/Protease/Amylase	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	suppressed
Levemir	Insulin Detemir	40	suppressed
Lubiprostone	Lubiprostone	39	suppressed
Meloxicam	Meloxicam	39	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Rivastigmine	Rivastigmine Tartrate	38	suppressed
Timolol Maleate	Timolol Maleate	36	suppressed
Cefuroxime	Cefuroxime Axetil	35	22
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	35	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	19
Jantoven	Warfarin Sodium	34	suppressed
Lidocaine	Lidocaine	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Ceftriaxone	Ceftriaxone Sodium	32	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	29	suppressed
Heparin Sodium	Heparin Sodium,porcine	29	suppressed
Humalog	Insulin Lispro	29	11
Sodium Chloride	0.9 % Sodium Chloride	28	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	27	suppressed
Dantrolene Sodium	Dantrolene Sodium	27	suppressed
Klor-Con 10	Potassium Chloride	27	suppressed
Ondansetron Odt	Ondansetron	27	25
Levemir Flexpen	Insulin Detemir	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Linzess	Linaclotide	23	suppressed
Thiothixene	Thiothixene	23	suppressed
Dilt-Xr	Diltiazem Hcl	22	suppressed
Humulin R	Insulin Regular, Human	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Tivicay	Dolutegravir Sodium	22	suppressed
Acetazolamide	Acetazolamide	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Micafungin	Micafungin Sodium	20	suppressed
Multaq	Dronedarone Hcl	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Lactulose	Lactulose	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	19	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Minocycline Hcl	Minocycline Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	12
Colchicine	Colchicine	17	suppressed
Lidocaine Hcl	Lidocaine Hcl	17	11
Methenamine Hippurate	Methenamine Hippurate	17	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	16	11
Celecoxib	Celecoxib	16	suppressed
Mexiletine Hcl	Mexiletine Hcl	16	suppressed
Olanzapine Odt	Olanzapine	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Azithromycin	Azithromycin	15	11
Insulin Lispro	Insulin Lispro	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Novolin R	Insulin Regular, Human	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Valsartan	Valsartan	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Dalfampridine Er	Dalfampridine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Insulin Aspart	Insulin Aspart	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Dutasteride	Dutasteride	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Nystatin	Nystatin	12	suppressed
Riluzole	Riluzole	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Abacavir	Abacavir Sulfate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Risperidone Odt	Risperidone	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$66.48 · 3 records	Novo Nordisk Inc	CT THROMBECTOMY SYSTEM KIT, FLOWTRIEVER CATHETER, S, REXULTI, Wegovy	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error